Tech Company Financing Transactions
Moonwalk Biosciences Funding Round
On 9/8/2026, Moonwalk Biosciences secured $70 million in Series B financing from Alpha Wave Ventures, YK Bioventures and Arch Venture Partners.
Transaction Overview
Company Name
Announced On
9/8/2026
Transaction Type
Venture Equity
Amount
$70,000,000
Round
Series B
Investors
Alpha Wave Ventures (Lead Investor)
YK Bioventures (Lead Investor)
Proceeds Purpose
The company intends to use the funds to support advancement of its lead obesity candidate, MW101, into first-in-human clinical studies in late 2027, expand its pipeline of tissue-targeted siRNA medicines, and further advance its proprietary discovery platform.
Company Information
Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
2 Tower Place, 17th Floor
San Francisco, CA 94080
USA
San Francisco, CA 94080
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Moonwalk Biosciences is an early-stage therapeutics company co-founded by Dr. Feng Zhang and leading experts in cell state epigenetics including Alex Aravanis, the former CTO of Illumina.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Alex Aravanis
Chief Operating Officer
Justin Valley
President
Arash Jamshidi
VP - Bus. Development
Elaine Cheung
Browse more venture capital transactions:
Prev: 9/7/2026: Jaipur Robotics venture capital transaction
Next: 9/8/2026: Keep Converting venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on tech company VC transactions. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs